๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX ยท Real-Time Price ยท USD
14.27
+0.45 (3.26%)
Nov 18, 2026, 12:11 PM EST - Market open

ADARx Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Revenue
6.133.45-
Revenue Growth
---
Gross Profit
-83.74-68.06-43.36
Operating Income
-106.3-88.37-58.23
Net Income
-87.87-73.09-46.36
Earnings Per Share
-9.07-7.54-4.94
EPS Growth
---

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Cash & Investments
427.25480219.48
Total Debt
6.97.744.33
Net Cash (Debt)
420.35472.26215.15
Net Cash Growth
-119.50%-
Net Cash Per Share
43.3948.7022.93

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Cash Flow
-88.32262.29-48.56
Capital Expenditures
-1.89-2.94-0.46
Free Cash Flow
-90.21259.35-49.02
Free Cash Flow Growth
---

Margins

Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Margin
-1734.98%-2562.05%-
Pretax Margin
-1434.14%-2119.11%-
Profit Margin
-1434.14%-2119.11%-
FCF Margin
-1472.37%7519.66%-